Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1299)
111, Inc. (YI)
Chen Yang Luke — Director
Shares
44,000
Price
$0.18
Total Value
$7.92K
Shares Held After
451,462
% of Holdings
8.9%
Progyny, Inc. (PGNY)
Swartz Allison — EVP, GC
Shares
3,903
Price
$26.10
Total Value
$101.87K
Shares Held After
75,816
% of Holdings
4.9%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
2,846
Price
$36.36
Total Value
$103.48K
Shares Held After
176,545
% of Holdings
1.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
220
Price
$390.52
Total Value
$85.92K
Shares Held After
9,000
% of Holdings
2.4%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
1,935
Price
$389.71
Total Value
$754.09K
Shares Held After
9,220
% of Holdings
17.3%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
1,341
Price
$388.76
Total Value
$521.33K
Shares Held After
11,155
% of Holdings
10.7%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
2,846
Price
$387.74
Total Value
$1.10M
Shares Held After
12,496
% of Holdings
18.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
2,300
Price
$386.64
Total Value
$889.27K
Shares Held After
15,342
% of Holdings
13.0%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
390
Price
$385.29
Total Value
$150.26K
Shares Held After
17,642
% of Holdings
2.2%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
110
Price
$390.42
Total Value
$42.95K
Shares Held After
9,000
% of Holdings
1.2%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
2,320
Price
$389.69
Total Value
$904.07K
Shares Held After
9,110
% of Holdings
20.3%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
1,293
Price
$388.71
Total Value
$502.60K
Shares Held After
11,430
% of Holdings
10.2%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
2,734
Price
$387.65
Total Value
$1.06M
Shares Held After
12,723
% of Holdings
17.7%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
2,175
Price
$386.71
Total Value
$841.10K
Shares Held After
15,457
% of Holdings
12.3%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
400
Price
$385.10
Total Value
$154.04K
Shares Held After
17,632
% of Holdings
2.2%
CYPHERPUNK TECHNOLOGIES INC. (CYPH)
Martin Patricia A. — Director
Shares
50,000
Price
$3.86
Total Value
$193.00K
Shares Held After
118,750
% of Holdings
29.6%
Adagene Inc. (ADAG)
Tam Man Kin — Director
Shares
2,000
Price
$3.00
Total Value
$6.00K
Shares Held After
12,000
% of Holdings
16.7%
Medpace Holdings, Inc. (MEDP)
Troendle August J. — Director
Shares
16,083
Price
$628.64
Total Value
$10.11M
Shares Held After
417,289
% of Holdings
3.7%
908 Devices Inc. (MASS)
AWM Investment Company, Inc. — 10% Owner
Shares
1,000
Price
$11.25
Total Value
$11.25K
Shares Held After
4,755,773
% of Holdings
0.0%
Pharvaris N.V. (PHVS)
Monges Viviane — Director
Shares
11,969
Price
$33.05
Total Value
$395.52K
Shares Held After
5,500
% of Holdings
68.5%
Anixa Biosciences Inc (ANIX)
Titterton Lewis H jr — Director
Shares
49,036
Price
$2.69
Total Value
$131.91K
Shares Held After
1,046,003
% of Holdings
4.7%
Aktis Oncology, Inc. (AKTS)
Czibere Akos — Chief Medical Officer
Shares
7,401
Price
$21.03
Total Value
$155.65K
Shares Held After
0
% of Holdings
100.0%
Aktis Oncology, Inc. (AKTS)
Czibere Akos — Chief Medical Officer
Shares
5,099
Price
$20.19
Total Value
$102.97K
Shares Held After
7,401
% of Holdings
40.8%
AtriCure, Inc. (ATRC)
Privitera Salvatore — Chief Technical Officer
Shares
4,519
Price
$60.00
Total Value
$271.14K
Shares Held After
142,745
% of Holdings
3.1%
OMEROS CORP (OMER)
Borges David J. — VP, Finance&CAO
Shares
10,000
Price
$20.95
Total Value
$209.50K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$500.05
Total Value
$120.01K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
90
Price
$498.90
Total Value
$44.90K
Shares Held After
324,683
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
270
Price
$498.38
Total Value
$134.56K
Shares Held After
324,773
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
766
Price
$497.27
Total Value
$380.91K
Shares Held After
325,043
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
525
Price
$496.38
Total Value
$260.60K
Shares Held After
325,809
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
155
Price
$495.17
Total Value
$76.75K
Shares Held After
326,334
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$493.72
Total Value
$79.00K
Shares Held After
326,489
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$492.54
Total Value
$236.42K
Shares Held After
326,649
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
824
Price
$491.65
Total Value
$405.12K
Shares Held After
327,129
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,440
Price
$490.48
Total Value
$706.29K
Shares Held After
327,953
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,162
Price
$489.52
Total Value
$1.06M
Shares Held After
329,393
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,388
Price
$488.70
Total Value
$1.17M
Shares Held After
331,555
% of Holdings
0.7%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
4,528
Price
$1.61
Total Value
$7.29K
Shares Held After
0
% of Holdings
100.0%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
114,851
Price
$1.61
Total Value
$184.91K
Shares Held After
0
% of Holdings
100.0%
Butterfly Network, Inc. (BFLY)
DEVIVO JOSEPH — Director
Shares
3,169
Price
$10.02
Total Value
$31.76K
Shares Held After
7,347,720
% of Holdings
0.0%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
4,528
Price
$1.61
Total Value
$7.29K
Shares Held After
0
% of Holdings
100.0%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
114,851
Price
$1.61
Total Value
$184.91K
Shares Held After
0
% of Holdings
100.0%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
43
Price
$41.05
Total Value
$1.77K
Shares Held After
456,767
% of Holdings
0.0%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
215
Price
$39.86
Total Value
$8.57K
Shares Held After
456,810
% of Holdings
0.0%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
1,952
Price
$39.05
Total Value
$76.23K
Shares Held After
457,025
% of Holdings
0.4%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
30,000
Price
$99.40
Total Value
$2.98M
Shares Held After
380,209
% of Holdings
7.3%
111, Inc. (YI)
Chen Yang Luke — Director
Shares
44,000
Price
$0.18
Total Value
$7.92K
Shares Held After
451,462
% of Holdings
8.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,900
Price
$1.05
Total Value
$2.00K
Shares Held After
383,885
% of Holdings
0.5%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
5,318
Price
$2.10
Total Value
$11.17K
Shares Held After
2,855,318
% of Holdings
0.2%
Inhibrx Biosciences, Inc. (INBX)
Kayyem Jon Faiz — Director
Shares
5,000
Price
$100.00
Total Value
$500.00K
Shares Held After
434,360
% of Holdings
1.2%
1299 transactions